BOT s share price is subject to the same pressures that it was...

BOT s share price is subject to the same pressures that it was before June, no proven products in the pipeline, just a lot of promising ones. 1 billion shares on issue which means that there are always sellers at any price level or release of a positive announcement. The next Phase II results have been seriously affected by BTX1503 because the same people who set up the latter trial did the next one, so there is a lot of inherent risk. In addition a lot of people have lost confidence and it will take a while for this to return and with no news expected for an extended period the share price is going to continue to go up and down around the present level. If the trial results for BTX1204 are not really good this company will be rerated downwards even further and be reduced to a penny stock in the true meaning of the phrase.